Lord's Mark Industries Ltd.

Based in India, Lord's Mark Industries Ltd. focuses on preventive genetic testing, providing innovative insights into health conditions through comprehensive DNA analysis, empowering users to manage their health proactively. Lord's Mark Industries Ltd. specializes in genetic testing services for health management.

Founded in 1998 and headquartered in Mumbai, India, the company has successfully catered to a growing market in preventive healthcare. The founder has a history of entrepreneurial ventures, although specific details about prior companies are not disclosed. In November 2025, Lord's Mark Industries Ltd. acquired a majority stake in Renalyx Health Systems Private Limited from Canbank Venture.

MyDNA specializes in preventive genetic testing, acting as a personal health detective by analyzing genetic variants within an individual's DNA. This technology provides critical insights into health conditions and identifies potential future health risks. The company's core offerings include tests for cancer susceptibility, cardiovascular health, medication response, and beauty-related genetic variations. MyDNA serves a diverse clientele, including individuals, healthcare providers, and hospitals, enhancing accessibility to genetic testing across urban and rural areas in India and potentially other international markets.

MyDNA's revenue model is based on the sale of genetic testing services through direct-to-consumer channels and partnerships with healthcare providers. Clients purchase testing kits for sample collection, which are analyzed to produce health reports. Their transaction structure includes one-time purchases or subscription services for ongoing health monitoring. Pricing plans align with the intensity of analysis and insights, with flagship tests for cancer risk and cardiovascular health being significant contributors to their revenue stream.

Looking ahead, Lord's Mark Industries Ltd. plans to introduce new genetic testing products aimed at expanding their market reach. The company intends to enter new geographic regions, including Southeast Asia and the Middle East, by 2025. Recent funding will be allocated to enhance research and development for these upcoming products and to support marketing efforts targeting these new markets.